Jackson Hole Capital Partners, LLC Gilead Sciences, Inc. Transaction History
Jackson Hole Capital Partners, LLC
- $470 Million
- Q3 2024
A detailed history of Jackson Hole Capital Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 32,373 shares of GILD stock, worth $2.92 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
32,373
Previous 30,294
6.86%
Holding current value
$2.92 Million
Previous $2.08 Million
30.56%
% of portfolio
0.58%
Previous 0.46%
Shares
22 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...